News
Academy
Publications
Media
Conferences
Columns
Resources
Webcasts
Subscribe

|Articles|February 19, 2019

Shimmer Launches Verisense Wearable Sensor Platform for Clinical Trials

Shimmer, a company that makes wearable technology for research applications, launched Verisense, its next-generation wearable sensor platform for clinical trial sponsors, sites, and participants.

Read the full release here.

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Related Content

SCOPE Summit 2026: Making ESG a Core Measure of Clinical Research Quality

ByOtis Johnson, PhD, MPA,Andy Studna, Senior Editor

February 9th 2026

Semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist approved as Ozempic for type 2 diabetes and as Wegovy for weight management, has demonstrated robust and clinically meaningful weight loss in randomized controlled trials, as well as in real-world evidence settings. Credit: Stock.Adobe.com/Tobias Arhelger.

Interdependence-Aware Attribution in Real-World Evidence: A Case Study on Semaglutide Weight Loss Outcomes

ByEytan Ellenberg, MD, MPH, PhD

February 9th 2026

SCOPE Summit 2026: How Sponsors Are Prioritizing AI Adoption Across Clinical Trials

ByRaja Shankar,Andy Studna, Senior Editor

February 9th 2026

As the clinical research ecosystem becomes more digitally connected, embedding AI is easier than ever, making the promise of streamlined, transparent financial management a reality. Credit: Stock.Adobe.com/GamePixel.

Accelerate Clinical Trials with AI-Enhanced Financial Management

ByRajesh Patel,Zahiah (Zee Zee) Gueddar

February 6th 2026

SCOPE Summit 2026: Reducing Patient Burden Is the Foundation of Wearable Success in Oncology

ByJeremy Wyatt,Andy Studna, Senior Editor

February 6th 2026

Trending on Applied Clinical Trials Online

Accelerate Clinical Trials with AI-Enhanced Financial Management

SCOPE Summit 2026 Panel Discussion: Diversity in Clinical Trials—What’s Working, What’s Next

Interdependence-Aware Attribution in Real-World Evidence: A Case Study on Semaglutide Weight Loss Outcomes

SCOPE Summit 2026: How Sponsors Are Prioritizing AI Adoption Across Clinical Trials

SCOPE Summit 2026: Elevating Patient Experience in Clinical Operations